PREFIX fhir: <http://hl7.org/fhir/> 
PREFIX fhirvs: <http://hl7.org/fhir/ValueSet/>
PREFIX xsd: <http://www.w3.org/2001/XMLSchema#> 
PREFIX rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> 


#imported_begin 
IMPORT <Period.shex>
#imported_end
#imported_begin 
IMPORT <dateTime.shex>
#imported_end
#imported_begin 
IMPORT <BackboneType.shex>
#imported_end
#imported_begin 
IMPORT <CodeableConcept.shex>
#imported_end
# The marketing status describes the date when a medicinal product is actually put on the market or the date as of which it is no longer available
<MarketingStatus> EXTENDS @<BackboneType> CLOSED {   

    a [fhir:MarketingStatus]?;
    fhir:nodeRole [fhir:treeRoot]?;

    fhir:country @<CodeableConcept>?;       # The country in which the marketing 
                                            # authorization has been granted 
                                            # shall be specified It should be 
                                            # specified using the ISO 3166 ‑ 1 
                                            # alpha-2 code elements 
    fhir:jurisdiction @<CodeableConcept>?;  # Where a Medicines Regulatory 
                                            # Agency has granted a marketing 
                                            # authorization for which specific 
                                            # provisions within a jurisdiction 
                                            # apply, the jurisdiction can be 
                                            # specified using an appropriate 
                                            # controlled terminology The 
                                            # controlled term and the controlled 
                                            # term identifier shall be specified 
    fhir:status @<CodeableConcept>;         # This attribute provides 
                                            # information on the status of the 
                                            # marketing of the medicinal product 
                                            # See ISO/TS 20443 for more 
                                            # information and examples 
    fhir:dateRange @<Period>?;              # The date when the Medicinal 
                                            # Product is placed on the market by 
                                            # the Marketing Authorization Holder 
                                            # (or where applicable, the 
                                            # manufacturer/distributor) in a 
                                            # country and/or jurisdiction shall 
                                            # be provided A complete date 
                                            # consisting of day, month and year 
                                            # shall be specified using the ISO 
                                            # 8601 date format NOTE “Placed on 
                                            # the market” refers to the release 
                                            # of the Medicinal Product into the 
                                            # distribution chain 
    fhir:restoreDate @<dateTime>?;          # The date when the Medicinal 
                                            # Product is placed on the market by 
                                            # the Marketing Authorization Holder 
                                            # (or where applicable, the 
                                            # manufacturer/distributor) in a 
                                            # country and/or jurisdiction shall 
                                            # be provided A complete date 
                                            # consisting of day, month and year 
                                            # shall be specified using the ISO 
                                            # 8601 date format NOTE “Placed on 
                                            # the market” refers to the release 
                                            # of the Medicinal Product into the 
                                            # distribution chain 
}  

